Reuters Health Report

Click to View in Browser 04/3/2014 Drugmaker Novartis files patent suit against Biocon over Galvus ZURICH (Reuters) - Novartis has taken India's Biocon to court for infringing the patent on its diabetes drug Galvus, the Swiss drugmaker said in a statement on Thursday. Fertility drugs not tied to long term breast cancer risk NEW YORK (Reuters Health) - Despite concerns and some evidence that fertility treatments increase a woman's chances of developing breast cancer, a large, long term study finds no added risk. Amgen ends marketing agreement with GSK for osteoporosis drug (Reuters) - Amgen Inc said it was ending an agreement with GlaxoSmithKline Plc, under which the British company marketed Amgen's postmenopausal osteoporosis drug in some regions outside the United States. France alerts doctors for any signs of Ebola from West Africa PARIS (Reuters) - French health authorities on Thursday put doctors and hospitals on alert to report any signs that an Ebola virus outbreak affecting West Africa had infected patients in France, though no symptoms had yet been detected. Britain may make firms standardize cigarette packets next year LONDON (Reuters) - Britain looked set to force tobacco companies to standardize cigarette packaging after a government review said on Thursday that the move would help cut smoking rates, although ministers were criticized for delaying a final decision. Miners in lock-down in Guinea as Ebola death toll hits 84 CONAKRY/GENEVA (Reuters) - Foreign mining firms have locked down operations in Guinea and pulled out some international staff, executives said on Wednesday, as the death toll from suspected cases of Ebola there hit 84. Australia's cigarette plain packaging debate clouded by lack of data SYDNEY (Reuters) - More than a year after Australia became the first country to introduce plain packaging for cigarettes, there is little hard evidence to prove the trailblazing move is worth emulating. FDA bans imports from Canadian drugmaker Apotex's India plant MUMBAI (Reuters) - The U.S. Food and Drug Administration banned imports from Canadian drugmaker Apotex Inc's manufacturing plant in India for not complying with quality standards, the latest in a series of sanctions against medicines produced in India. UK doctors paid $64 million by drug companies in 2013 LONDON (Reuters) - Doctors in Britain were paid 38.5 million pounds ($64 million) by drugmakers last year, slightly less than 2012, according to new data underscoring the links between the pharmaceutical industry and prescribers. Healthcare players see more changes coming to Obamacare WASHINGTON (Reuters) - Some of the key players rolling out Obamacare to the American public say their work on the program is just beginning, as the real-world effect of the law throws up new questions and problems. Related Video Chileans return home to survey damage after earthquake Titanium golf clubs a fire risk: scientists The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend